Scarsi, Claudia

Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the New Food and Drug Administration potency guidelines in healthy volunteers under fasting conditions

Colucci, P., D'Angelo, P., Mautone, G., Scarsi, C., & Ducharme, M. P. (2011) · Therapeutic Drug Monitoring

Thyroid Disorders and TreatmentsPharmaceutical studies and practices

Cited by 45

When bioequivalence in healthy volunteers may not translate to bioequivalence in patients: differential effects of increased gastric pH on the pharmacokinetics of levothyroxine capsules and tablets

Seng Yue, C., Benvenga, S., Scarsi, C., Loprete, L., & Ducharme, M. (2015) · Journal of Pharmacy & Pharmaceutical Sciences

Thyroid Disorders and TreatmentsDrug Solubulity and Delivery Systems

Cited by 41

Pharmacokinetics and comparative bioavailability of a levothyroxine sodium oral solution and soft capsule

Tanguay, M., Girard, J., Scarsi, C., Mautone, G., & Larouche, R. (2019) · Clinical Pharmacology in Drug Development

Thyroid Disorders and TreatmentsDrug Solubulity and Delivery Systems

Cited by 33

A novel levothyroxine solution results in similar bioavailability whether taken 30 or just 15 minutes before a high-fat high-calorie meal

Ducharme, M., Scarsi, C., Bettazzi, E., Mautone, G., Lewis, Y., & Celi, F. S. (2022) · Thyroid

Thyroid Disorders and TreatmentsDrug Solubulity and Delivery Systems

Cited by 13

Levothyroxine soft capsules demonstrate bioequivalent pharmacokinetic exposure with the European reference tablets in healthy volunteers under fasting conditions

Al-Numani, D., Scarsi, C., & Ducharme, M. P. (2016) · Int. Journal of Clinical Pharmacology and Therapeutics

Thyroid Disorders and TreatmentsPharmaceutical studies and practices

Cited by 12